FEATURES OF LIPID METABOLISM DISORDERS IN PATIENTS WHO HAVE EXPERIENCED COVID-19 AND ITS CORRECTION WITH ROZUVASTATIN (literature review)
Keywords:
dyslipidemia, rosuvastatin, COVID-19, lipid metabolism, metabolic processAbstract
The purpose of this overview scientific work is to analyze the clinical and pathogenetic mechanisms of lipid metabolism disorders in patients who have undergone COVID-19 and to evaluate the effectiveness of treatment with rozuvastatin. SARS-CoV-2 has a systemic effect on metabolic processes, including lipid metabolism, manifested by the development of dyslipidemia, which contributes to an increased cardiovascular risk. The article examines the mechanisms of these disorders, their relationship with post-COVID syndrome, and presents data on the positive effects of rosevastatin on lipid profile and inflammatory markers in such patients.
References
Мазуров В.В., Чазова И.Е. Липидный обмен и COVID-19. Кардиология, 2022;62(6):45–51.
Клинические рекомендации МЗ РФ: «Дислипидемии» (2023).
Мазуров В.В., Чазова И.Е. Липидный обмен и COVID-19. Кардиология, 2022;62(6):45–51.
Kumar A. et al. Statin therapy in COVID-19 survivors: a meta-analysis. Int J Cardiol, 2024;377:121–128.
Rizzo M. et al. Effects of rosuvastatin in patients recovering from COVID-19: A prospective cohort study. Metabolism, 2023;134:155261.
Rohatgi A. et al. Dyslipidemia post-COVID: mechanisms and management. J Clin Lipidol, 2023;17(1):13–22.
Toth P.P. et al. Statins and inflammation: insights from COVID-19. J Clin Lipidol, 2021;15(3):287–294.
Triggiani M., Gentile M., De Matteis G. et al. Role of lipid profile and statins in COVID-19 prognosis and recovery // Journal of Clinical Medicine. — 2023. — Vol. 12(1). — P. 112–121.
Tajbakhsh A., Gheibi Hayat S.M., Johnston T.P. et al. The impact of COVID-19 on lipid metabolism and potential therapeutic role of statins: a narrative review // Current Problems in Cardiology. — 2023. — Vol. 48, No. 2. — Article 101362.
Sabatine M.S., Wiviott S.D. Rosuvastatin and its place in lipid-lowering therapy // Circulation. — 2021. — Vol. 143, No. 5. — P. 507–510.
Singh S., Khan A., Chowdhury M.A. Effects of statins on clinical outcomes in hospitalized patients with COVID-19: a systematic review and meta-analysis // Journal of the American Heart Association. — 2022. — Vol. 11, No. 1. — Article e023835.
WHO. COVID-19 Clinical management: living guidance. Updated 2024.
Zhang X. et al. Lipid metabolism in COVID-19: mechanisms and therapeutic targets. Frontiers in Physiology, 2022;13:845987.
